During the past decade, Acellacare of Wilmington conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Acellacare of Wilmington" are "Pneumococcal Vaccines" (2 trials). Many other conditions were trialed in "Acellacare of Wilmington" in a lesser frequency.

Most popular intervention types in "Acellacare of Wilmington" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "20 valent pneumococcal conjugate vaccine" (1 trials), "24 valent pneumococcal conjugate vaccine" (1 trials), "24-Valent Pneumococcal Conjugate Vaccine" (1 trials) and "Pneumococcal 20-valent Conjugate Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Acellacare of Wilmington" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Acellacare of Wilmington". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Acellacare of Wilmington, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Acellacare of Wilmington, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".